Content Area: Outdoor Air
Indicator: Annual PM2.5 Level (Monitor only)
|
| Annual average ambient concentrations of PM2.5 in (micrograms per cubic meter) |
|
 |
|
|
Content Area: Outdoor Air
Indicator: Annual PM2.5 Level (Monitor + Modeled)
|
| Annual average ambient concentrations of PM2.5 in micrograms per cubic meter |
|
|
|
|
Content Area: Outdoor Air
Indicator: Ozone - Days above regulatory standard (Monitor only)
|
| Number of days with maximum 8-hour average ozone concentration over the National Ambient Air Quality Standard |
|
|
|
| Number of person-days with maximum 8-hour average ozone concentration over the National Ambient Air Quality Standard |
|
|
|
|
Content Area: Outdoor Air
Indicator: Ozone - Days above regulatory standard (Monitor + Modeled)
|
| Number of days with maximum 8-hour average ozone concentration over the NAAQS |
|
|
|
| Number of person-days with max 8-hour average ozone concentration over the NAAQS |
|
|
|
|
Content Area: Outdoor Air
Indicator: PM2.5 - Days above regulatory standard (Monitor only)
|
| Percent of days with PM2.5 levels over the National Ambient Air Quality Standard (NAAQS) |
|
|
|
| Person-days with PM2.5 over the National Ambient Air Quality Standard |
|
|
|
|
Content Area: Outdoor Air
Indicator: PM2.5 - Days above regulatory standard (Monitor + Modeled)
|
| Number of person-days with PM2.5 over the NAAQS |
|
|
|
| Percent of days with PM2.5 levels over the NAAQS |
|
|
|
|
Content Area: Air Quality
Indicator: Mortality benefits associated with reducing PM2.5 concentration levels
( Note : Only default reduction rate (10%) results are displayed here by year. Please check Query Panel for all the results )
|
| Estimated number of deaths prevented |
|
|
|
| Estimated percent change in death rate from baseline |
|
|
|
| Ranked groupings of counties based on percent change in death rate from baseline |
|
|
|
|
Content Area: Asthma
Indicator: Asthma Prevalence among Adults
|
| Percent of adults ever diagnosed with asthma |
|
|
|
| Percent of adults ever diagnosed with asthma who report they currently have asthma |
|
|
|
| Percent of adults with active asthma diagnosed within the past 5 years |
|
|
|
| Percent of adults with active asthma with an attack in the past year |
|
|
|
| Percent of adults with active asthma with one or more routine doctor's visit in the past year |
|
|
|
|
Content Area: Asthma
Indicator: Asthma Prevalence among Children
|
| Percent of children ever diagnosed with asthma |
|
|
|
| Percent of children ever diagnosed with asthma who report they currently have asthma |
|
|
|
|
Content Area: Asthma
Indicator: Hospitalizations for Asthma
|
| Age-adjusted rate of hospitalization for asthma per 10,000 population |
|
|
|
| Crude rate of hospitalization for asthma per 10,000 population |
|
|
|
| Number of hospitalizations for asthma |
|
|
|
|
Content Area: Biomonitoring: Population Exposures
Indicator: Levels of Environmental Chemicals in Blood and Urine
|
| Total Arsenic concentrations in urine |
|
|
|
| Benzene concentrations in blood in 20- 59 year olds (ng/mL) |
|
|
|
| Cadmium concentrations in urine |
|
|
|
| Cadmium concentrations in blood(µg/L) |
|
|
|
| Chloroform concentrations in blood in 20- 59 year olds (pg/mL) |
|
|
|
| Cotinine concentrations in blood serum in non-smokers (ng/mL ) |
|
|
|
| Lead concentrations in blood (µg/dL ) |
|
|
|
| Total Mercury concentrations in urine |
|
|
|
| Total Mercury concentrations in blood (µg/L ) |
|
|
|
| Naphthalene metabolite, 1- Hydroxynaphthalene concentrations in urine |
|
|
|
| Pyrene metabolite, 1-Hydroxypyrene concentrations in urine |
|
|
|
| Toluene concentrations in blood in 20- 59 year olds (ng/mL) |
|
|
|
| Uranium concentrations in urine |
|
|
|
| Naphthalene metabolite, 2- Hydroxynaphthalene concentrations in urine |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Anencephaly
|
| Average annual number of cases of Anencephaly among live births over five year period |
|
|
|
| Prevalence of Anencephaly per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Cleft Lip with or without Cleft Palate
|
| Average annual number of cases of Cleft Lip with or without Cleft Palate among live births over a five year period |
|
|
|
| Prevalence of Cleft Lip with or without Cleft Palate per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Cleft Palate without Cleft Lip
|
| Average annual number of cases of Cleft Palate without Cleft Lip among live births over a five year period |
|
|
|
| Prevalence of Cleft Palate without Cleft Lip per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Gastroschisis
|
| Average annual number of cases of Gastroschisis among live births over a five year period |
|
|
|
| Prevalence of Gastroschisis per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Hypoplastic Left Heart Syndrome
|
| Average annual number of cases of Hypoplastic Left Heart Syndrome among live births over a five year period |
|
|
|
| Prevalence of Hypoplastic Left Heart Syndrome per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Hypospadias
|
| Average annual number of cases of Hypospadias among live births over a five year period |
|
|
|
| Prevalence of Hypospadias per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Lower Limb Deficiencies
|
| Average annual number of cases of Lower Limb Deficiencies among live births over a five year period |
|
|
|
| Prevalence of Lower Limb Deficiencies per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Spina Bifida w/out Anencephaly
|
| Average annual number of cases of Spina Bifida w/out Anencephaly among live births over a five year period |
|
|
|
| Prevalence of Spina Bifida (without Anencephaly) per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Tetralogy of Fallot
|
| Average annual number of cases of Tetralogy of Fallot among live births over a five year period |
|
|
|
| Prevalence of Tetralogy of Fallot per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Transposition of the Great Arteries (Vessels)
|
| Average annual number of cases of Transposition of the Great Arteries (Vessels) among live births over a five year period |
|
|
|
| Prevalence of Transposition of the Great Arteries (vessels) per 10,000 live births over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Trisomy 21
|
| Average annual number of cases of Trisomy 21 to mothers less than 35 years of age at delivery over a five year period |
|
|
|
| Average annual number of cases of Trisomy 21 to mothers 35 to 59 years of age at delivery over a five year period |
|
|
|
| Prevalence of Trisomy 21 per 10,000 live births to mothers less than 35 years of age at delivery over a five year period |
|
|
|
| Prevalence of Trisomy 21 per 10,000 live births to mothers 35 to 59 years of age at delivery over a five year period |
|
|
|
|
Content Area: Birth Defects
Indicator: Prevalence of Upper Limb Deficiencies
|
| Average annual number of cases of Upper Limb Deficiencies among live births over a five year period |
|
|
|
| Prevalence of Upper Limb Deficiencies per 10,000 live births over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Acute Myeloid Leukemia
|
| Age-adjusted incidence rate of Acute Myeloid Leukemia per 100,000 population |
|
|
|
| Annual number of cases of Acute Myeloid Leukemia |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Bladder Cancer
|
| Age-adjusted incidence rate of Bladder Cancer (including in situ) per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Bladder Cancer (including in situ) per 100,000 population over a five year period |
|
|
|
| Annual number of cases of Bladder Cancer (including in situ) |
|
|
|
| Average annual number of cases of Bladder Cancer (including in situ) over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Brain and Other Nervous System Cancer
|
| Age-adjusted incidence rate of Brain and Other Nervous System Cancer per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Brain and Other Nervous System Cancer per 100,000 population over a five year period |
|
|
|
| Annual number of cases of Brain and Other Nervous System Cancer |
|
|
|
| Average annual number of cases of Brain and Other Nervous System Cancer over a five year period over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Breast Cancer (Females Only)
|
| Age-adjusted incidence rate of Breast Cancer per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Breast Cancer per 100,000 population over a five year period |
|
|
|
| Annual number of cases of Breast Cancer |
|
|
|
| Average annual number of cases of Breast Cancer over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Chronic Lymphocytic Leukemia
|
| Age-adjusted incidence rate of Chronic Lymphocytic Leukemia per 100,000 population |
|
|
|
| Annual number of cases of Chronic Lymphocytic Leukemia |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Leukemia
|
| Age-adjusted incidence rate of Leukemia per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Leukemia per 100,000 population over a five year period |
|
|
|
| Annual number of cases of Leukemia |
|
|
|
| Average annual number of cases of Leukemia over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Lung and Bronchus Cancers
|
| Age-adjusted incidence rate of Lung and Bronchus Cancer per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Lung and Bronchus Cancer per 100,000 population over a five year period |
|
|
|
| Annual number of cases of Lung and Bronchus Cancer |
|
|
|
| Average annual number of cases of Lung and Bronchus Cancer over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Non-Hodgkin's Lymphoma
|
| Age-adjusted incidence rate of Non-Hodgkin's Lymphoma per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Non-Hodgkin's Lymphoma per 100,000 population over a five year period |
|
|
|
| Annual number of cases of Non-Hodgkin's Lymphoma |
|
|
|
| Average annual number of cases of Non-Hodgkin's Lymphoma over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Thyroid Cancers
|
| Age-adjusted incidence rate of Thyroid Cancer per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Thyroid Cancer per 100,000 population over a five year period |
|
|
|
| Annual number of cases of Thyroid Cancer |
|
|
|
| Average annual number of cases of Thyroid Cancer over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Mesothelioma
|
| Average annual number of cases of Mesothelioma over a five year period |
|
|
|
| Age-adjusted incidence rate of Mesothelioma per 100,000 population over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Melanoma of the Skin
|
| Annual number of cases of Melonoma of the Skin |
|
|
|
| Average annual number of cases of Melanoma of the Skin over a five year period |
|
|
|
| Age-Adjusted incidence rate of Melanoma of the Skin per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Melanoma of the Skin per 100,000 population over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Kidney and Renal Pelvis Cancer
|
| Annual number of cases of Kidney and Renal Pelvis Cancer |
|
|
|
| Average annual number of cases of Kidney and Renal Pelvis Cancer over a five year period |
|
|
|
| Age-Adjusted incidence rate of Kidney and Renal Pelvis Cancer per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Kidney and Renal Pelvis Cancer per 100,000 population over a five year period |
|
|
|
|
Content Area: Cancer
Indicator: Incidence of Liver and Intrahepatic Bile Duct Cancer
|
| Annual number of cases of Liver and Intrahepatic Bile Duct Cancer |
|
|
|
| Average annual number of cases of Liver and Intrahepatic Bile Duct Cancer over a five year period |
|
|
|
| Age-Adjusted incidence rate of Liver and Intrahepatic Bile Duct Cancer per 100,000 population |
|
|
|
| Age-adjusted incidence rate of Liver and Intrahepatic Bile Duct Cancer per 100,000 population over a five year period |
|
|
|
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
